Home › Funds › Values First Advisors, Inc. › LMAT

Values First Advisors, Inc. position in LMAT

LEMAITRE VASCULAR INC · Health Care

Values First Advisors, Inc. reported holding 18,642 shares of LMAT (LEMAITRE VASCULAR INC) in its Q3 2026 13F filing — a position valued at US$1.5M, representing 0.72% of its reported portfolio and ranking #48 among its reported holdings. Values First Advisors, Inc. has disclosed LMAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)18.64K sh
Reported value held$1.54M
Portfolio Weight0.72%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Values First Advisors, Inc.'s LMAT position evolved

Values First Advisors, Inc. first disclosed a stake in LMAT in Q3 2023 at 32,991 shares (US$1.8M). The position peaked in Q3 2024 at 27,740 shares, worth US$2.6M. Across 13 filings, Values First Advisors, Inc. increased the stake 1 time(s), trimmed it 10 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 18,642 shares valued at US$1.5M — a reduction of -316 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 32.99K $1.80M New
Q4 2023 33.62K $1.91M Add
Q1 2024 32.97K $2.19M Reduce
Q2 2024 28.07K $2.31M Reduce
Q3 2024 27.74K $2.58M Reduce
Q4 2024 26.52K $2.44M Reduce
Q1 2025 26.61K $2.23M Hold
Q2 2025 21.35K $1.77M Reduce
Q3 2025 21.18K $1.85M Reduce
Q4 2025 20.31K $1.65M Reduce
Q1 2026 20.20K $2.20M Reduce
Q2 2026 18.96K $1.82M Reduce
Q3 2026 18.64K $1.54M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LMAT and 13F data

LMAT (LEMAITRE VASCULAR INC) is a Health Care company. 34 other funds we track also report a position in LMAT — the largest reported positions include Copeland Capital Management, LLC (US$76.3M), Conestoga Capital Advisors, LLC (US$72.6M), GENEVA CAPITAL MANAGEMENT LLC (US$42.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LMAT

All LMAT fund holders →

FAQ

How long has Values First Advisors, Inc. held LMAT?

Values First Advisors, Inc. has disclosed LMAT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Values First Advisors, Inc.'s current position in LMAT?

As of Q3 2026, Values First Advisors, Inc. holds 18.64K shares of LMAT (LEMAITRE VASCULAR INC), valued at $1.54M, representing 0.72% of its reported portfolio and ranking #48.

Has Values First Advisors, Inc. been buying or selling LMAT?

In the latest 13F filing (Q3 2026), Values First Advisors, Inc. reduced its position in LMAT. The position peaked in Q3 2024 at 27.74K shares.

Which other funds hold LMAT?

Other major institutional holders of LMAT include Copeland Capital Management, LLC, Conestoga Capital Advisors, LLC, GENEVA CAPITAL MANAGEMENT LLC, among 34 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.